Foghorn Therapeutics Inc (NAS:FHTX)
$ 6.67 -0.15 (-2.19%) Market Cap: 396.40 Mil Enterprise Value: 272.81 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 67/100

Foghorn Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 04:10 PM GMT
Release Date Price: $5.52 (-4.17%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

FHTX.OQ - Foghorn Therapeutics Inc
Foghorn Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 04:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, ladies and gentlemen.

Thank you very much for coming up to the TD Cowan forty-sixth annual healthcare conference. My name is Steven Einov on the biotech team, and you joining me is the management of Hawthorne Therapeutics. With presenting today is Doctor Adrian Gottschalk, President and CEO, who will give a presentation, and I might have a few questions afterwards. Doctor Gottschalk, take it away.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Great, thank you, Steven. Yo, nice to see you.

Thank you to the, TD Cowan folks for
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot